DÄ internationalArchiveReferences


The Investigation and Treatment of Female Pelvic Floor Dysfunction

Dtsch Arztebl Int 2015; 112: 564-74. DOI: 10.3238/arztebl.2015.0564

Jundt, K; Peschers, U; Kentenich, H

1. Harninkontinenz. Gesundheitsberichterstattung des Bundes. Robert Koch-Institut. Band 39; 2007
2. Onder G, Carpenter I, Finne-Soveri H, et al. SHELTER project: Assessment of nursing home residents in Europe: the Services and Health for Elderly in Long TERm care (SHELTER) study. BMC Health Serv Res 2012; 12: 5 CrossRef MEDLINE PubMed Central
3. Abrams P, Cardozo L, Fall M, et al: The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002; 21(2): 167–178 CrossRef MEDLINE
4.Hannestad YS, Rortveit G, Sandvik H, et al.: A community-based epidemiological survey of female urinary incontinence: The Norwegian EPINCONT Study. J Clin Epidemiol 2000; 53: 1150–7 CrossRef
5.Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, Bratt H: Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Community Health. 1993; 47: 497–9 CrossRef
6.Bitzer, J: Psychosomatik der Miktionsstörungen der Frau. In: Stauber M, Kentenich H, Richter D (eds.): Psychosomatische Geburtshilfe und Gynäkologie. Berlin Heidelberg: Springer-Verlag 1999; 522–531 CrossRef
7.Walters MD, Taylor S, Schoenfeld LS: Psychosexual study of women with detrusor instability. Obstet Gynecol 1990; 75: 22–26 MEDLINE
8.Schoenfeld M, Fuermetz A, Muenster M, et al.: Sexuality in German urogynecological patients and healthy controls: is there a difference with respect to the diagnosis? Eur J Obstet Gynecol Reprod Biol 2013; 170: 567–70 CrossRef MEDLINE
9.Coyne KS, Sexton CC, Kopp ZS, et al.: The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden : results from EpiLUTS. BJU Int 2011; 108: 1459–71 MEDLINE
10.Heidler S, Mert C, Wehrberger C, et al.: Impact of overactive bladder symptoms on sexuality in both sexes. Urol Int 2010; 85: 443–6 CrossRef CrossRef MEDLINE
11. Rortveit G, Daltveit AK, Hannestad YS, Hunskaar S: Urinary incontinence after vaginal delivery or cesarean section.N Engl J Med 2003; 348: 900–7 CrossRef MEDLINE
12.Gyhagen M, Bullarbo M, Nielsen TF, Milsom I: Prevalence and risk factors for pelvic organ prolapse 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery. BJOG 2013; 120: 152–60 CrossRef MEDLINE
13.Reisenauer C, Muche-Borowski C, Anthuber C, et al.: Interdisziplinäre S2e-Leitlinie für die Diagnostik und Therapie der Belastungsinkontinenz der Frau. Geburtsh Frauenheilk 2013; 73: 1–5.
14.Jundt K, Scheer I, Schiessl B, Pohl K, Haertl K, Peschers UM: Physical and sexual abuse in patients with overactive bladder: is there an association? Int Urogynecol J Pelvic Floor Dysfunct. 2007; 18: 449–53 CrossRef MEDLINE
15.Lucas MG, Bosch RJ, Burkhard FC, et al.: EAU guidelines on surgical treatment of urinary incontinence. Actas Urol Esp 2013; 37: 459–72 CrossRef CrossRef MEDLINE
16. Viereck V, Rautenberg O, Kociszewski J, Grothey S, Welter J, Eberhard J: Midurethral sling incision: indications and outcomes. Int Urogynecol J 2013; 24: 645–53 CrossRef MEDLINE PubMed Central
17.Schäfer W, Abrams P, Liao L, et al.: Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002; 21: 261–74 CrossRef MEDLINE
18.AMWF: Die überaktive Blase. 2010. AWMF 015/007 (S2k). www.awmf.org/uploads/tx_szleitlinien/015–007l_S2k_Ueberaktive_Blase_2010-abgelaufen.pdf (last accessed on 10 July 2015).
19.Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A: Oestrogen therapy for urinary incontinence in postmenopausal women. Cochrane Database Syst Rev 2012; 10: CD001405 MEDLINE
20.Dumoulin C, Hay-Smith EJ, Mac Habée-Séguin G: Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2014; 5: CD005654 CrossRef
21.Hay-Smith EJC, Dumoulin C: Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Syst Rev 2006,1: CD005654 CrossRef
22.Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, McClinton S: Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2012 2: CD003881 CrossRef
23.Novara G, Artibani W, Barber MD, et al.: Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol 2010; 58: 218–38 CrossRef MEDLINE
24.Bø K: Pelvic floor muscle training in treatment of female stress urinary incontinence, pelvic organ prolapse and sexual dysfunction. World J Urol 2012; 30: 437–43 CrossRef MEDLINE
25.Hagen S, Stark D: Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2011; 12: CD003882 CrossRef
26.Bugge C, Adams EJ, Gopinath D, Reid F. Pessaries (mechanical devices) for pelvic organ prolapse in women. Cochrane Database Syst Rev 2013; 2: CD004010 CrossRef
27.Zhang FW, Wei F, Wang HL, et. al.: Does pelvic floor muscle training augment the effect of surgery in women with pelvic organ prolapse? A systematic review of randomized controlled trials. Neurourol Urodyn 2015. doi: 10.1002/nau.22784. [Epub ahead of print CrossRef
28.Maher CM, Feiner B, Baessler K, Glazener CM: Surgical management of pelvic organ prolapse in women: the updated summary version Cochrane review. Int Urogynecol J 2011; 22: 1445–57 CrossRef MEDLINE
29.Vigod SN, Steward DE: Major depression in female urinary incontinence. Psychosomatics 2006; 47: 147–51 CrossRef MEDLINE
30.Debus G, Kästner R: Psychosomatic aspects of urinary incontinence in women. Geburtshilfe Frauenheilkd 2015; 75: 165–9 CrossRef MEDLINE PubMed Central
31.Hunskaar S: A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn 2008; 27: 749–57 CrossRef MEDLINE
32.Fong ED, Nitti VW: Review article: Mid-urethral synthetic slings for female stress urinary incontinence. BJU Int 2010; 106: 596–608 CrossRef MEDLINE
33.Lapitan MC, Cody JD: Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2012; 6: CD002912 CrossRef
34.Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, McClinton S: Urethral injection therapy for urinary incontinence in women. Cochrane Database of Syst Rev. 2012; 2: CD003881 CrossRef
35.Herderschee R, Hay-Smith EJC., Herbison GP, Roovers JP, Heineman MJ: Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Syst Rev. 2011; 7: CD009252 CrossRef
36.Rai BP, Cody JD, Alhasso A, Stewart L: Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2012; 12: CD003193 CrossRef
37.Duthie JB, Vincent M, Herbison GP, Wilson DIain, Wilson D: Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2011, 12: CD005493 MEDLINE
38.Noblett K, Siegel S, Mangel J et al.: Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder. Neurourol Urodyn 2014. doi: 10.1002/nau.22707. [Epub ahead of print CrossRef
39.Bugge C, Hagen S, Thakar R. Vaginal pessaries for pelvic organe prolapse and urinary incontinence: a multiprofessional survey of practice. Int Urogynecol J 2013; 24: 1017–24 CrossRef MEDLINE
40.AWMF: Deszensus genitalis der Frau. AWMF 015/006 (S1). Aktuelle Version 2015 im Druck (S2e).
e1.Fantl JA, Newman DK, Colling J. et al.: Urinary incontinence in adults: acute and chronic management. Clinical Practice Guideline No. 2, 1996 Update. Rockville, MD
e2.Saga S, Vinsnes AG, Mørkved S, Norton C, Seim A: What characteristics predispose to continence in nursing home residents?: A population-based cross-sectional study. Neurourol Urodyn 2015; 34: 362–7 CrossRef MEDLINE PubMed Central
e3.Nuotio M, Jylha M, Luukkaala T, Tammela TL: Urinary incontinence in a Finish population aged 70 and over. Prevalence of types, associated factors and self-reported treatments. Scan J Prim Health Care 2003; 21: 182–7 MEDLINE
e4.Samuelsson E, Victor A, Tibblin G: A population study of urinary incontinence and nocturia among women aged 20–59 years. Prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand 1997; 76: 74–80 CrossRef MEDLINE
e5.Samuelsson EC, Victor FT, Tibblin G, Svärdsudd KF: Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol 1999; 180: 299–305 CrossRef
e6.Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A: Pelvic organ prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002; 186: 1160–6 CrossRef
e7.Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL: Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997; 89: 501– CrossRef
e8.Fialkow MF, Newton KM, Lentz GM, Weiss NS: Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 437–3 CrossRef MEDLINE
e9.Smith FJ, Holman CD, Moorin RE, Tsokos N: Lifetime risk undergoing surgery for pelvic organ prolapse. Obstet Gynecol 2010; 116: 1096–100 CrossRef MEDLINE
e10.Yang JM, Yang SH, Yang SY, Yang E, Huang WC, Tzeng CR: Clinical and pathophysiological correlates of the symptom severity of stress urinary incontinence. Int Urogynecol J 2010; 21: 637–43 CrossRef MEDLINE
e11.Ghoniem G, Stanford E, Kenton K, et al.: Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 5–33 CrossRef MEDLINE PubMed Central
e12.Bø K, Finckenhagen HB: Vaginal palpation of pelvic floor muscle strength: inter-test reproducibility and comparison between palpation and vaginal squeeze pressure. Acta Obstet Gynecol Scand 2001; 80: 883–7 CrossRef CrossRef
e13.Jundt K, Scheer I, von Bodungen V, Krumbachner F, Friese K, Peschers UM: What harm does a second delivery to the pelvic floor? Eur J Med Res 2010; 15: 362–6 CrossRef MEDLINE PubMed Central
e14.Shek KL, Chantarasorn V, Dietz HP: The urethral motion profile before and after suburethral sling placement. J Urol 2010; 183: 1450–4 CrossRef MEDLINE
e15.Dickie KJ, Shek KL, Dietz HP: The relationship between urethral mobility and parity. BJOG 2010; 117: 1220–4 CrossRef MEDLINE
e16.Huang WC, Yang SH, Yang SY, Yang E, Yang JM: The correlations of incontinence-related quality of life measures with symptom severity and pathophysiology in women with primary stress urinary incontinence. World J Urol 2010; 28: 619–23 CrossRef MEDLINE
e17.Steensma AB, Konstantinovic ML, Burger CW, de Ridder D, Timmerman D, Deprest J: Prevalence of major levator abnormalities in symptomatic patients with an underactive pelvic floor contraction. Int Urogynecol J 2010; 21: 861–7 CrossRef MEDLINE PubMed Central
e18.Avery KN, Bosch JL, Gotoh M, et al.: Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol 2007; 177: 39–49 CrossRef MEDLINE
e19.Bjelic-Radisic V, Dorfer M, Tamussino K, Greimel E: Psychometric properties and validation of the German-language King’s Health Questionnaire in women with stress urinary incontinence. Neurourol Urodyn 2005; 24: 63–8 CrossRef MEDLINE
e20.Baessler K, Kempkensteffen C: [Validation of a comprehensive pelvic floor questionnaire for the hospital, private practice and research]. Validierung eines umfassenden Beckenboden-Fragebogens fur Klinik, Praxis und Forschung. Gynakol Geburtshilfliche Rundsch 2009; 49: 299–307 CrossRef MEDLINE
e21.Baessler K, Junginger B: [Validation of a pelvic floor questionnaire with improvement and satisfaction scales to assess symptom severity, bothersomeness and quality of life before and after pelvic floor therapy]. Beckenboden-Fragebogen fur Frauen. Validierung eines Instrumentes mit posttherapeutischem Modul zur Evaluation von Symptomen, Leidensdruck, Lebensqualitat, Verbesserung und Zufriedenheit. Aktuelle Urol 2011; 42: 316–22 MEDLINE
e22.Imamura M, Abrams P, Bain C, et al.: Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess 2010; 14: 1–188 CrossRef MEDLINE
e23.Farrell SA, Baydock S, Amir B, Fanning C: Effectiveness of a new self-positioning pessary for the management of urinary incontinence in women. Am J Obstet Gynecol 2007; 196: 474 e1–8 MEDLINE
e24.Noblett KL, McKinney A, Lane FL: Effects of the incontinence dish pessary on urethral support and urodynamic parameters. Am J Obstet Gynecol 2008; 198: 592 e1–5 MEDLINE
e25.Mariappan P, Alhasso A, Ballantyne Z, Grant A, N’Dow J: Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol 2007; 51: 67–74 CrossRef MEDLINE
e26.Shamliyan TA, Kane RL,Wyman J, Wilt TJ: Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008; 148: 459–73 CrossRef
e27.Mostafa A, Lim CP, Hopper L, Madhuvrata P, Abdel-Fattah M: Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: an updated systematic review and meta-analysis of effectiveness and complications. Eur Urol 2014; 65: 402–27 CrossRef MEDLINE
e28.Agur W, Riad M, Secco S, et al.: Surgical treatment of recurrent stress urinary incontinence in women: a systematic review and meta-analysis of randomised controlled trials. Eur Urol 2013; 64: 323–3 CrossRef MEDLINE
e29.Magee G, Roy S, Hinoul P, et al.: A real-world comparative assessment of complications following various mid-urethral sling procedures for the treatment of stress urinary incontinence. J Long Term Eff Med Implants.2012; 22: 329–40 CrossRef MEDLINE
e30.Nilsson CG, Palva K, Aarnio R, Morcos E, Falconer C: Seventeen years’ follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J 2013; 24: 1265–9 CrossRef MEDLINE
e31.Ward K, Hilton P: Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ 2002; 325: 67 CrossRef
e32.Jelovsek JE, Barber MD, Karram MM, Walters MD, Paraiso MF: Randomised trial of laparoscopic Burch colposuspension versus tension-free vaginal tape: long-term follow up. BJOG 2008; 115: 219–25; discussion 225 MEDLINE
e33.Wang AC, Wang YY, Chen MC: Single-blind, randomized trial of pelvic floor muscle training, biofeedback-assisted pelvic floor muscle training, and electrical stimulation in the management of overactive bladder. Urology 2004; 63: 61–6 CrossRef
e34.Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D: The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-analysis. Eur Urol 2008; 54: 543–62 CrossRef MEDLINE
e35.Veenboer PW, Bosch JL: Long-term adherence to antimuscarinic therapy in everyday practice: a systematic review. J Urol 2014; 191: 1003–8 CrossRef MEDLINE
e36.Nitti VW, Dmochowski R, Herschorn S, et al.: EMBARK Study Group: OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol 2013; 189: 2186–93 CrossRef CrossRef MEDLINE
e37.Schurch B, Schmid DM, Stöhrer M: Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 2000; 342: 665 CrossRef MEDLINE
e38.Hanson LA, Schulz JA, Flood CG, Cooley B, Tam F: Vaginal pessaries in managing women with pelvic organ prolapse and urinary incontinence: patient characteristics and factors contributing to success. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17: 155–9 CrossRef MEDLINE
e39.Clemons JL, Aguilar VC, Sokol ER, Jackson ND, Myers DL: Patient characteristics that are associated with continued pessary use versus surgery after 1 year. Am J Obstet Gynecol 2004; 191: 159–64 CrossRef
e40.Wiegersma M, Panman CM, Kollen BJ, et al.: Pelvic floor muscle training versus watchful waiting or pessary treatment for pelvic organ prolapse (POPPS): Design and participant baseline characteristics of two parallel pragmatic randomized controlled trials in primary care. Maturitas 2014; 77: 168–73 CrossRef MEDLINE
e41.Hsiao KC, Latchamsetty K, Govier FE, Kozlowski P, Kobashi KC: Comparison of laparoscopic and abdominal sacrocolpopexy for the treatment of vaginal vault prolapse. J Endourol 2007; 21: 926–30 CrossRef MEDLINE
e42.Barber MD, Maher C: Apical prolapse. Int Urogynecol J 2013; 24: 1815–33 CrossRef MEDLINE
e43.Abramov Y, Gandhi S, Goldberg RP, Botros SM, Kwon C, Sand PK: Site-specific rectocele repair compared with standard posterior colporrhaphy. Obstet Gynecol 2005; 105: 314–8 CrossRef MEDLINE